420 related articles for article (PubMed ID: 25350088)
21. Metabolic alterations in the peritumoral brain in cases of meningiomas: 1H-MRS study.
Chernov MF; Nakaya K; Kasuya H; Kato K; Ono Y; Yoshida S; Nakamura R; Suzuki T; Muragaki Y; Iseki H; Kubo O; Hori T; Takakura K
J Neurol Sci; 2009 Sep; 284(1-2):168-74. PubMed ID: 19497588
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.
Morana G; Piccardo A; Puntoni M; Nozza P; Cama A; Raso A; Mascelli S; Massollo M; Milanaccio C; Garrè ML; Rossi A
Neuro Oncol; 2015 Dec; 17(12):1637-47. PubMed ID: 26405202
[TBL] [Abstract][Full Text] [Related]
23. Short TE proton MRS and neurofibromatosis type 1 intracranial lesions.
Norfray JF; Darling C; Byrd S; Ross BD; Schwalm C; Miller R; Tomita T
J Comput Assist Tomogr; 1999; 23(6):994-1003. PubMed ID: 10589584
[TBL] [Abstract][Full Text] [Related]
24. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
Appenzeller S; Li LM; Costallat LT; Cendes F
Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of diffusion-weighted magnetic resonance imaging at 3.0 Tesla for differentiation between intracranial neoplastic and noninfectious inflammatory lesions in dogs.
Maclellan MJ; Ober CP; Feeney DA; Jessen CR
J Am Vet Med Assoc; 2019 Jul; 255(1):71-77. PubMed ID: 31194666
[TBL] [Abstract][Full Text] [Related]
26. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y
Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899
[TBL] [Abstract][Full Text] [Related]
27. Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy.
Zeng Q; Liu H; Zhang K; Li C; Zhou G
Magn Reson Imaging; 2011 Jan; 29(1):25-31. PubMed ID: 20832225
[TBL] [Abstract][Full Text] [Related]
28. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
29. Utilization of glutamate/creatine ratios for proton spectroscopic diagnosis of meningiomas.
Hazany S; Hesselink JR; Healy JF; Imbesi SG
Neuroradiology; 2007 Feb; 49(2):121-7. PubMed ID: 17086406
[TBL] [Abstract][Full Text] [Related]
30. Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up.
Castellino G; Govoni M; Padovan M; Colamussi P; Borrelli M; Trotta F
Ann Rheum Dis; 2005 Jul; 64(7):1022-7. PubMed ID: 15640271
[TBL] [Abstract][Full Text] [Related]
31. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
32. Proton magnetic resonance spectroscopy of brain-stem lesions.
Smith JK; Londono A; Castillo M; Kwock L
Neuroradiology; 2002 Oct; 44(10):825-9. PubMed ID: 12389131
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic challenge of lack of choline level elevation on 1H-MR spectroscopy in grade II-III gliomas.
Bobek-Billewicz B; Heinze S; Majchrzak K; Mazgaj P; Hebda A
Folia Neuropathol; 2024; 62(1):13-20. PubMed ID: 38741433
[TBL] [Abstract][Full Text] [Related]
34. A methodological approach for deep learning to distinguish between meningiomas and gliomas on canine MR-images.
Banzato T; Bernardini M; Cherubini GB; Zotti A
BMC Vet Res; 2018 Oct; 14(1):317. PubMed ID: 30348148
[TBL] [Abstract][Full Text] [Related]
35. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI.
Yang D; Korogi Y; Sugahara T; Kitajima M; Shigematsu Y; Liang L; Ushio Y; Takahashi M
Neuroradiology; 2002 Aug; 44(8):656-66. PubMed ID: 12185543
[TBL] [Abstract][Full Text] [Related]
36. Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.
Tong ZY; Toshiaki Y; Wang YJ
Chin Med J (Engl); 2005 Aug; 118(15):1251-7. PubMed ID: 16117877
[TBL] [Abstract][Full Text] [Related]
37. MRS study of meningeal hemangiopericytoma and edema: a comparison with meningothelial meningioma.
Righi V; Tugnoli V; Mucci A; Bacci A; Bonora S; Schenetti L
Oncol Rep; 2012 Oct; 28(4):1461-7. PubMed ID: 22824994
[TBL] [Abstract][Full Text] [Related]
38. Lack of choline elevation on proton magnetic resonance spectroscopy in grade I-III gliomas.
Chawla S; Lee SC; Mohan S; Wang S; Nasrallah M; Vossough A; Krejza J; Melhem ER; Nabavizadeh SA
Neuroradiol J; 2019 Aug; 32(4):250-258. PubMed ID: 31050313
[TBL] [Abstract][Full Text] [Related]
39. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
40. Malignancy of brain tumors evaluated by proton magnetic resonance spectroscopy (1H-MRS) in vitro.
Czernicki Z; Horsztyński D; Jankowski W; Grieb P; Walecki J
Acta Neurochir Suppl; 2000; 76():17-20. PubMed ID: 11449999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
